Abstract
First-in-Human Trial of BCMA-CD19 Compound CAR (cCAR) in Desensitization of Donor-Specific Anti-HLA Antibodies (DSAs) in Haploidentical Stem Cell Transplant Recipients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have